» Articles » PMID: 16473856

Epidermolysis Bullosa. I. Molecular Genetics of the Junctional and Hemidesmosomal Variants

Overview
Journal J Med Genet
Specialty Genetics
Date 2006 Feb 14
PMID 16473856
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Epidermolysis bullosa (EB), a group of autosomal heritable blistering diseases, is characterised by extensive phenotypic variability with considerable morbidity and mortality. EB is classified into distinct subtypes depending on the location of blistering within the cutaneous dermoepidermal basement membrane zone. Ten genes are known to harbour mutations in the major types of EB, and the level of expression of these genes within the cutaneous basement membrane zone and in extracutaneous tissues, as well as the types and combinations of the mutations, explain in general terms the phenotypic variability.

Methods: The DebRA Molecular Diagnostics Laboratory, established in 1996 and supported in part by the patient advocacy organisation DebRA of America, has analysed over 1000 families with different forms of EB.

Results: In total, 265 cases were submitted with the preliminary diagnosis of junctional or hemidesmosomal forms of EB. We found 393 mutant alleles in seven different genes, with 173 of the mutations being distinct and 71 previously unpublished.

Discussion: These findings attest to the clinical and molecular heterogeneity of the junctional and hemidesmosomal subtypes of EB. The results also reveal exceptions to the general rules on genotype-phenotype correlations, unusual phenotypes, and surprising genetics. Collectively, mutation analysis in different forms of EB provides the basis for improved classification with prognostic implications and for prenatal and preimplantation diagnosis in families at risk for recurrence of EB.

Citing Articles

Identification of deep intronic variants in junctional epidermolysis bullosa using genome sequencing and splicing assays.

Chen F, Wei R, Wang Y, Cao Q, Wang J, Wang C NPJ Genom Med. 2025; 10(1):8.

PMID: 39915495 PMC: 11802722. DOI: 10.1038/s41525-025-00466-8.


Novel readthrough agent suppresses nonsense mutations and restores functional type VII collagen and laminin 332 in epidermolysis bullosa.

Levian B, Hou Y, Tang X, Bainvoll L, Zheng K, Badarinarayana V Mol Ther Nucleic Acids. 2024; 35(4):102334.

PMID: 39391765 PMC: 11465179. DOI: 10.1016/j.omtn.2024.102334.


Highlights of Gene and Cell Therapy for Epidermolysis Bullosa and Ichthyosis.

Koutsoukos S, Bilousova G Dermatol Ther (Heidelb). 2024; 14(9):2379-2392.

PMID: 39112824 PMC: 11393223. DOI: 10.1007/s13555-024-01239-4.


Skin Microbial Composition and Genetic Mutation Analysis in Precision Medicine for Epidermolysis Bullosa.

Syafarina I, Mazaya M, Indrawati A, Akbar S, Sukowati C, Sadikin R Curr Drug Targets. 2024; 25(6):404-415.

PMID: 38566380 DOI: 10.2174/0113894501290512240327091531.


Gene-edited cells: novel allogeneic gene/cell therapy for epidermolysis bullosa.

Gila F, Alamdari-Palangi V, Rafiee M, Jokar A, Ehtiaty S, Dianatinasab A J Appl Genet. 2024; 65(4):705-726.

PMID: 38459407 DOI: 10.1007/s13353-024-00839-2.


References
1.
Pulkkinen L, McGrath J, Christiano A, Uitto J . Detection of sequence variants in the gene encoding the beta 3 chain of laminin 5 (LAMB3). Hum Mutat. 1995; 6(1):77-84. DOI: 10.1002/humu.1380060115. View

2.
Takizawa Y, Shimizu H, Pulkkinen L, Suzumori K, Kakinuma H, Uitto J . Combination of a novel frameshift mutation (1929delCA) and a recurrent nonsense mutation (W610X) of the LAMB3 gene in a Japanese patient with Herlitz junctional epidermolysis bullosa, and their application for prenatal testing. J Invest Dermatol. 1998; 111(6):1239-41. DOI: 10.1038/sj.jid.5600370. View

3.
Mellerio J, Pulkkinen L, McMillan J, Lake B, Horn H, Tidman M . Pyloric atresia-junctional epidermolysis bullosa syndrome: mutations in the integrin beta4 gene (ITGB4) in two unrelated patients with mild disease. Br J Dermatol. 1999; 139(5):862-71. DOI: 10.1046/j.1365-2133.1998.02515.x. View

4.
Uitto J, Richard G . Progress in epidermolysis bullosa: genetic classification and clinical implications. Am J Med Genet C Semin Med Genet. 2004; 131C(1):61-74. DOI: 10.1002/ajmg.c.30035. View

5.
Posteraro P, De Luca N, Meneguzzi G, El Hachem M, Angelo C, Gobello T . Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa. J Invest Dermatol. 2004; 123(4):639-48. DOI: 10.1111/j.0022-202X.2004.23302.x. View